Celosome Series · Cheekbone augmentation, jawline, chin, nose reshaping Celosome Implant — Highest-Density HENM Filler for Deep Facial Augmentation Celosome Implant is ExCoBio’s highest-viscosity variant — 24 mg/mL cross-linked HA 0.3% lidocaine engineered specifically for deep subcutaneous to supraperiosteal placement. The most structural Celosome variant for cheekbone augmentation, chin projection, non-surgical rhinoplasty, and jawline contouring. 12–24 month durability per manufacturer data. Professional use only — for licensed aesthetic practitioners. Manufacturer: ExCoBio Co. Ltd., South Korea · Established 2017 HENM Implant Grade 8-Phase Purification May 2026 Last Reviewed · Verified ExCoBio Co. Ltd. Technology How Celosome Implant Hyaluronic Acid Filler with Lidocaine Is Engineered 1 HENM 8-Phase Purification (Implant Grade) ExCoBio Co. Ltd.’s proprietary cross-linking process produces a stabilised HA gel matrix engineered for sustained tissue retention. The technology balances viscoelasticity (firmness for projection) with extrusion smoothness (easier injection through the 27G needle). The result: predictable handling, consistent gel distribution, and 12–24 months durability in subcutaneous placement. 2 Quality & Purity Non-animal hyaluronic acid produced by bacterial fermentation. Endotoxin levels controlled below international safety thresholds. Stringent manufacturing under GMP-certified conditions minimises BDDE residue, heavy metals, and protein contaminants — reducing the risk of post-injection inflammation, granuloma formation, or hypersensitivity reactions in suitable patient profiles. Composition Celosome Implant Hyaluronic Acid Filler with Lidocaine Active Ingredients Cross-Linked Hyaluronic Acid 24 mg/mL Non-animal hyaluronic acid produced by bacterial fermentation, cross-linked using ExCoBio Co. Ltd.’s HENM 8-Phase Purification (Implant Grade) technology. The cross-linking process creates a stable, durable gel matrix that resists rapid enzymatic breakdown in tissue. Phosphate-buffered saline carries the gel at near-physiological pH. Lidocaine HCl 0.3% (3 mg/mL) Premixed local anaesthetic at the industry-standard 0.3% concentration. Reduces injection-site discomfort and eliminates the need for on-site mixing with separate lidocaine vials. The lidocaine itself wears off within hours of injection and does not affect long-term gel duration. Clinical Indications Where Celosome Implant Hyaluronic Acid Filler with Lidocaine Is Used Cheekbone Augmentation Primary indication. Deep subcutaneous and supraperiosteal placement for sustained zygomatic projection and midface lift. Chin Augmentation Non-surgical chin projection and profile enhancement. Supraperiosteal placement is standard. Non-Surgical Rhinoplasty Nasal bridge enhancement and dorsum refinement. Off-label use requiring advanced vascular anatomy knowledge. Jawline Contouring Mandibular angle definition and gonial enhancement. The implant-grade viscosity supports angular projection. Side-By-Side Celosome Implant Hyaluronic Acid Filler with Lidocaine vs Juvederm vs Restylane Feature Celosome Juvederm (Allergan) Restylane (Galderma) HA Concentration 24 mg/mL 15–24 mg/mL 20 mg/mL Cross-Linking Tech HENM Vycross / Hylacross NASHA® / OBT Lidocaine 0.3% (premixed) 0.3% (XC lines) 0.3% (Lidocaine variants) Duration 12–24 months 6–24 months (varies) 6–18 months (varies) Origin South Korea (ExCoBio Co. Ltd.) USA (Allergan / AbbVie) Sweden (Galderma) Established Since 2017 2006 1996 ↔ Swipe horizontally on mobile to view all columns Comparison based on manufacturer published data. See our top dermal filler comparison guide for broader market context. Specifications Celosome Implant Hyaluronic Acid Filler with Lidocaine Product Specifications Manufacturer Brand: Celosome Company: ExCoBio Co. Ltd. Country: South Korea Established: 2017 Formula HA Source: Non-animal bacterial fermentation HA Concentration: 24 mg/mL Lidocaine: 0.3% (3 mg/mL) premixed Cross-linking: HENM 8-Phase Purification (Implant Grade) Performance Duration: 12–24 months Injection Depth: Subcutaneous · supraperiosteal Recommended Needle: 27G Last Reviewed: May 2026 Approval & Storage Approvals: KFDA registered · GMP certified Packaging: 1 × 1.1 mL pre-filled syringe Storage: 2–25 °C, do not freeze Shelf life: 24 months unopened Verify regulatory status at the official Korean MFDS database — nedrug.mfds.go.kr. For market pricing context, see our dermal filler pricing guide. FAQs Celosome Implant Hyaluronic Acid Filler with Lidocaine — Frequently Asked Questions What is Celosome Implant Hyaluronic Acid Filler with Lidocaine? Celosome Implant is ExCoBio’s highest-viscosity variant — 24 mg/mL cross-linked HA 0.3% lidocaine engineered specifically for deep subcutaneous to supraperiosteal placement. The most structural Celosome variant for cheekbone augmentation, chin projection, non-surgical rhinoplasty, and jawline contouring. 12–24 month durability per manufacturer data. Where is Celosome Implant Hyaluronic Acid Filler with Lidocaine manufactured? Celosome Implant Hyaluronic Acid Filler with Lidocaine is manufactured by ExCoBio Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 2017. The product is part of the Celosome dermal filler range, which is distributed across multiple international markets. Regulatory status: KFDA registered · GMP certified. What is the HA concentration in Celosome Implant Hyaluronic Acid Filler with Lidocaine? Celosome Implant Hyaluronic Acid Filler with Lidocaine contains 24 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using ExCoBio Co. Ltd.’s HENM 8-Phase Purification (Implant Grade) technology. Phosphate-buffered saline at near-physiological pH carries the gel. How long do Celosome Implant Hyaluronic Acid Filler with Lidocaine results last? Per ExCoBio Co. Ltd.’s clinical data, Celosome Implant Hyaluronic Acid Filler with Lidocaine delivers 12–24 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Subcutaneous placement typically delivers the longer end of the duration range. What is the recommended injection depth for Celosome Implant Hyaluronic Acid Filler with Lidocaine? Celosome Implant Hyaluronic Acid Filler with Lidocaine is engineered for subcutaneous · supraperiosteal placement. The standard recommended needle is 27G, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work. Is Celosome Implant Hyaluronic Acid Filler with Lidocaine FDA approved or CE marked? Celosome Implant Hyaluronic Acid Filler with Lidocaine regulatory status: KFDA registered · GMP certified. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use. How should Celosome Implant Hyaluronic Acid Filler with Lidocaine be stored at the clinic? Store Celosome Implant Hyaluronic Acid Filler with Lidocaine between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk. Does Celosome Implant Hyaluronic Acid Filler with Lidocaine contain animal-derived ingredients? No. Celosome Implant Hyaluronic Acid Filler with Lidocaine uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation). Can Celosome Implant Hyaluronic Acid Filler with Lidocaine be combined with other dermal fillers in the same session? Yes — layered protocols combining different fillers are standard aesthetic practice. Celosome Implant Hyaluronic Acid Filler with Lidocaine can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU. Why is Celosome Implant placed deeper than other variants? Celosome Implant’s highest viscosity in the range is specifically engineered for the subcutaneous and supraperiosteal tissue layers — where structural projection (cheekbones, chin, nose, jawline angle) requires firm support resistant to gravity and facial movement. Placing Implant in the superficial dermis would risk visible lumps and irregular contour. Conversely, placing lighter Celosome variants (Soft, Mid) in subcutaneous layers would dissipate too quickly to maintain projection. Related Products Other HA Dermal Fillers on Fillersfairy Celosome · South Korea Celosome Soft Hyaluronic Acid Filler Celosome Soft is ExCoBio’s lightest dermal filler — 24 mg/mL cross-linked HA 0.3% lidocaine produced via HENM cross-linking c… View product → Celosome · South Korea Celosome Mid Hyaluronic Acid Filler Celosome Mid is ExCoBio’s medium-density variant — 24 mg/mL cross-linked HA 0.3% lidocaine with HENM cross-linking and 8-phas… View product → Bellast · South Korea Bellast Soft L Hyaluronic Acid Filler Bellast Soft L is the lightest variant in DongkookPharma’s HCXL (High Concentration Cross-Linking) dermal filler series, formul… View product → Category All Dermal Fillers Browse our full range of HA dermal fillers, lip fillers, body fillers, and skin boosters for facial volume, contouring, and rejuvenation. Browse category → Important Safety Information Read Before Clinical Use Celosome Implant Hyaluronic Acid Filler with Lidocaine is a prescription medical device for use only by licensed aesthetic practitioners. Common reactions include injection-site bruising, swelling, redness, and tenderness — generally resolving within days. Deep placement (subcutaneous and supraperiosteal layers) involves heightened anatomical awareness of facial vasculature; practitioners require access to hyaluronidase for emergency dissolution. Like all hyaluronic acid dermal fillers, treatment carries rare but serious vascular complication risks. Contraindicated in patients with known hypersensitivity to hyaluronic acid or lidocaine, active skin infection at the treatment site, pregnancy, or breastfeeding. Full contraindications, vascular complication protocols, aftercare, and emergency guidance are detailed on the dermal filler safety page. Read Full Dermal Filler Safety Information → Celosome is a registered trademark of ExCoBio Co. Ltd.. Fillersfairy.com is a channel distributor and does not provide medical advice. This page is for informational purposes only and does not replace the manufacturer’s official Instructions for Use, which remains the authoritative source for clinical administration. Regulatory status varies by jurisdiction — buyers are responsible for verifying legal status before ordering. Last reviewed May 2026 against ExCoBio Co. Ltd. manufacturer documentation.